GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Revenue

AroCell AB (OSTO:AROC) Revenue : kr43.04 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB Revenue?

AroCell AB's revenue for the three months ended in Dec. 2023 was kr9.51 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr43.04 Mil. AroCell AB's Revenue per Share for the three months ended in Dec. 2023 was kr0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.19.

Warning Sign:

AroCell AB revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of AroCell AB was 8.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 471.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, AroCell AB's highest 3-Year average Revenue per Share Growth Rate was 471.80% per year. The lowest was -61.10% per year. And the median was 88.40% per year.


AroCell AB Revenue Historical Data

The historical data trend for AroCell AB's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB Revenue Chart

AroCell AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.08 12.00 36.99 43.04

AroCell AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.47 11.05 11.78 10.70 9.51

Competitive Comparison of AroCell AB's Revenue

For the Diagnostics & Research subindustry, AroCell AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's Revenue distribution charts can be found below:

* The bar in red indicates where AroCell AB's Revenue falls into.



AroCell AB Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr43.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB  (OSTO:AROC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


AroCell AB Revenue Related Terms

Thank you for viewing the detailed overview of AroCell AB's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock Announces Timing for First Quarter 2023 Results

By sperokesalga sperokesalga 04-25-2023

Archrock Publishes its 2021 Annual Sustainability Report

By PurpleRose PurpleRose 08-11-2022

Archrock Announces Timing for Second Quarter 2022 Results

By PurpleRose PurpleRose 07-18-2022

Archrock Announces Timing for First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-02-2022

Archrock (AROC): A Deep Dive into Its Overvaluation

By GuruFocus Research 09-27-2023

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire 10-26-2023

Archrock Announces Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 04-28-2022

Archrock Announces Quarterly Cash Dividend

By Value_Insider Value_Insider 10-27-2022

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire GlobeNewswire 07-28-2022